66 related articles for article (PubMed ID: 28456939)
1. Genetic Mutation of GluN2B Protects Brain Cells Against Stroke Damages.
Tang N; Wu J; Zhu H; Yan H; Guo Y; Cai Y; Yan H; Shi Y; Shu S; Pei L; Lu Y
Mol Neurobiol; 2018 Apr; 55(4):2979-2990. PubMed ID: 28456939
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of Neurite Outgrowth in Cerebrocortical Neurons by Sodium Channel Activator Brevetoxin-2 Requires Both N-Methyl-D-aspartate Receptor 2B (GluN2B) and p21 Protein (Cdc42/Rac)-Activated Kinase 1 (PAK1).
Mehrotra S; Pierce ML; Dravid SM; Murray TF
Mar Drugs; 2022 Aug; 20(9):. PubMed ID: 36135748
[TBL] [Abstract][Full Text] [Related]
3. DAPK1 Promotes Extrasynaptic GluN2B Phosphorylation and Striatal Spine Instability in the YAC128 Mouse Model of Huntington Disease.
Schmidt ME; Caron NS; Aly AE; Lemarié FL; Dal Cengio L; Ko Y; Lazic N; Anderson L; Nguyen B; Raymond LA; Hayden MR
Front Cell Neurosci; 2020; 14():590569. PubMed ID: 33250715
[TBL] [Abstract][Full Text] [Related]
4. Disease-associated missense mutations in GluN2B subunit alter NMDA receptor ligand binding and ion channel properties.
Fedele L; Newcombe J; Topf M; Gibb A; Harvey RJ; Smart TG
Nat Commun; 2018 Mar; 9(1):957. PubMed ID: 29511171
[TBL] [Abstract][Full Text] [Related]
5. Structure-Based Virtual Screening and Discovery of New Bi-functional DAPK1 Inhibitors.
Talwar P; Singh P; Ravanan P
Mol Biotechnol; 2024 Apr; 66(4):876-901. PubMed ID: 37351834
[TBL] [Abstract][Full Text] [Related]
6. Limb-Clasping Response in NMDA Receptor Palmitoylation-Deficient Mice.
Suzuki N; Oota-Ishigaki A; Kaizuka T; Itoh M; Yamazaki M; Natsume R; Abe M; Sakimura K; Mishina M; Hayashi T
Mol Neurobiol; 2024 Apr; ():. PubMed ID: 38592586
[TBL] [Abstract][Full Text] [Related]
7. Phase 1 Clinical Results for NP10679, a pH-sensitive GluN2B-selective N-methyl-d-aspartate Receptor Inhibitor.
Zaczek R; Traynelis SF; Dingledine R; Koszalka GW; Laskowitz DT
Clin Pharmacol Drug Dev; 2023 Jul; 12(7):706-717. PubMed ID: 36642931
[TBL] [Abstract][Full Text] [Related]
8. Functional assessment of the NMDA receptor variant GluN2A
Marwick KFM; Parker P; Skehel P; Hardingham G; Wyllie DJA
Wellcome Open Res; 2017 Mar; 2():20. PubMed ID: 28459106
[No Abstract] [Full Text] [Related]
9. Differential Nanoscale Topography and Functional Role of GluN2-NMDA Receptor Subtypes at Glutamatergic Synapses.
Kellermayer B; Ferreira JS; Dupuis J; Levet F; Grillo-Bosch D; Bard L; Linarès-Loyez J; Bouchet D; Choquet D; Rusakov DA; Bon P; Sibarita JB; Cognet L; Sainlos M; Carvalho AL; Groc L
Neuron; 2018 Oct; 100(1):106-119.e7. PubMed ID: 30269991
[TBL] [Abstract][Full Text] [Related]
10. DAPK1 Mediates LTD by Making CaMKII/GluN2B Binding LTP Specific.
Goodell DJ; Zaegel V; Coultrap SJ; Hell JW; Bayer KU
Cell Rep; 2017 Jun; 19(11):2231-2243. PubMed ID: 28614711
[TBL] [Abstract][Full Text] [Related]
11. Protopanaxadiol ginsenoside Rd protects against NMDA receptor-mediated excitotoxicity by attenuating calcineurin-regulated DAPK1 activity.
Zhang C; Liu X; Xu H; Hu G; Zhang X; Xie Z; Feng D; Wu R; Zhao G; Shi M
Sci Rep; 2020 May; 10(1):8078. PubMed ID: 32415270
[TBL] [Abstract][Full Text] [Related]
12. Presynaptic Caytaxin prevents apoptosis via deactivating DAPK1 in the acute phase of cerebral ischemic stroke.
Wang S; Chen K; Yu J; Wang X; Li Q; Lv F; Shen H; Pei L
Exp Neurol; 2020 Jul; 329():113303. PubMed ID: 32277960
[TBL] [Abstract][Full Text] [Related]
13. Pro-death NMDA receptor signaling is promoted by the GluN2B C-terminus independently of Dapk1.
McQueen J; Ryan TJ; McKay S; Marwick K; Baxter P; Carpanini SM; Wishart TM; Gillingwater TH; Manson JC; Wyllie DJA; Grant SGN; McColl BW; Komiyama NH; Hardingham GE
Elife; 2017 Jul; 6():. PubMed ID: 28731405
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for intraprocedural hypoxemia in patients with acute cerebral ischemia treated with vascular intervention and its impact on prognosis: A retrospective cohort study.
Gu Z; Yin A; Lu L; Lu Y; Jiang B; Yin L
Brain Circ; 2024; 10(1):42-50. PubMed ID: 38655442
[TBL] [Abstract][Full Text] [Related]
15. Autosomal Dominant Intellectual Development Disorder-6 (MRD6) Without Seizures Linked to a De Novo Mutation in the grin2b Gene Revealed by Exome Sequencing: A Case Report of a Moroccan Child.
El Mouhi H; Abbassi M; Sayel H; Trhanint S; Natiq A; El Hejjioui B; Jalte M; Ahmadi Y; Chaouki S
Cureus; 2023 Oct; 15(10):e46456. PubMed ID: 37927744
[TBL] [Abstract][Full Text] [Related]
16. Tonic Activation of NR2D-Containing NMDARs Exacerbates Dopaminergic Neuronal Loss in MPTP-Injected Parkinsonian Mice.
Sharma R; Neupane C; Pham TL; Lee M; Lee S; Lee SY; Nam MH; Kim CS; Park JB
J Neurosci; 2023 Nov; 43(46):7730-7744. PubMed ID: 37726169
[TBL] [Abstract][Full Text] [Related]
17. GluN2B-containing NMDARs in the mammalian brain: pharmacology, physiology, and pathology.
Ge Y; Wang YT
Front Mol Neurosci; 2023; 16():1190324. PubMed ID: 37324591
[TBL] [Abstract][Full Text] [Related]
18. Identification of DAPK1 as an autophagy-related biomarker for myotonic dystrophy type 1.
Hu M; Ge MR; Li HX; Zhang B; Li G
Front Genet; 2022; 13():1022640. PubMed ID: 36338967
[TBL] [Abstract][Full Text] [Related]
19. Excitatory Synaptic Transmission in Ischemic Stroke: A New Outlet for Classical Neuroprotective Strategies.
Wang F; Xie X; Xing X; Sun X
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012647
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
